Revista de informes de casos clínicos

Combined Therapy with New Triazole Agent (Isovocunazole) and Micafungin in Invasive Pulmonary Aspergillosis Complicated by Hemoptysis in Immunocompetent Patient

Abstract

Michele Gambardella1*, Antonino Crocamo1, Vincenzo Barlotti1, Augusto La Penna2, Gerarda Pirofalo3 and Giovanni D’Arena4

Apergillosis in immunocompetent critical patients has increased incidence over the past two decades. Patients at risk include those with systemic steroid therapies and deteriorate pulmonary functions (COPD). Hemoptysis is a devastating complication of pulmonary aspergillosis reported in 28.9% of cases.